These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 19998927)
1. Neurostabilizers for migraine prevention. From dosage administration to patient expectations. Wright W Adv Nurse Pract; 2007 Feb; 15(2):52-4, 56-8, 85. PubMed ID: 19998927 [No Abstract] [Full Text] [Related]
2. GABAergic drugs for the treatment of migraine. Puppe A; Limmroth V CNS Neurol Disord Drug Targets; 2007 Aug; 6(4):247-50. PubMed ID: 17691980 [TBL] [Abstract][Full Text] [Related]
3. [Valproic acid in prophylactic treatment of migraine]. Arnold G; Einhäupl KM Nervenarzt; 1998 Oct; 69(10):913-8. PubMed ID: 9834484 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the effect of topiramate and sodium valporate in migraine prevention: a randomized blinded crossover study. Shaygannejad V; Janghorbani M; Ghorbani A; Ashtary F; Zakizade N; Nasr V Headache; 2006 Apr; 46(4):642-8. PubMed ID: 16643559 [TBL] [Abstract][Full Text] [Related]
5. Migraine headache prophylaxis in adolescents. Fantasia HC Nurs Womens Health; 2014; 18(5):420-4. PubMed ID: 25316542 [TBL] [Abstract][Full Text] [Related]
11. Topiramate for migraine prevention in adolescents: a pooled analysis of efficacy and safety. Winner P; Gendolla A; Stayer C; Wang S; Yuen E; Battisti WP; Nye JS Headache; 2006; 46(10):1503-10. PubMed ID: 17115983 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological prophylaxis of chronic migraine: a review of double-blind placebo-controlled trials. D'Amico D Neurol Sci; 2010 Jun; 31 Suppl 1():S23-8. PubMed ID: 20464578 [TBL] [Abstract][Full Text] [Related]
13. A comparative study of the effects of low-dose topiramate versus sodium valproate in migraine prophylaxis. Afshari D; Rafizadeh S; Rezaei M Int J Neurosci; 2012 Feb; 122(2):60-8. PubMed ID: 21950578 [TBL] [Abstract][Full Text] [Related]
14. Migraine prevention: techniques are available, but underutilized. New guidelines emphasize ways to reduce the number of migraine attacks. Duke Med Health News; 2012 Jul; 18(7):6-7. PubMed ID: 22872904 [No Abstract] [Full Text] [Related]
15. FDA approves Topamax for migraine prevention in adolescents. J Pain Palliat Care Pharmacother; 2014 Jun; 28(2):191. PubMed ID: 25011147 [No Abstract] [Full Text] [Related]
16. [Prophylactic migraine treatment with topiramate]. Nagy F Ideggyogy Sz; 2010 Jul; 63(7-8):227-30. PubMed ID: 20812450 [TBL] [Abstract][Full Text] [Related]
17. Cost-minimization analysis comparing topiramate with standard treatments in migraine prophylaxis. Ergun H; Gulmez SE; Tulunay FC Eur Neurol; 2007; 58(4):215-7. PubMed ID: 17827966 [TBL] [Abstract][Full Text] [Related]
18. Topiramate-induced depression in cases using topiramate for migraine prophylaxis. Phabphal K; Udomratn P Cephalalgia; 2010 Jun; 30(6):747-9. PubMed ID: 19624688 [No Abstract] [Full Text] [Related]
19. [Chronic migraine: not well known but not rare!]. Straube A; Gaul C MMW Fortschr Med; 2011 Mar; 153(12):43-5. PubMed ID: 22165644 [No Abstract] [Full Text] [Related]
20. [Narrow-angle glaucoma and acute myopia from using topiramate as prophylactic treatment of migraine]. Rodríguez-Gómez D; Castro-Pérez A; Landaluce-Chaves ML; Cid-Rodríguez MC; Lustres-Pérez M; Gómez-Fernández RC Rev Neurol; 2007 Aug 16-31; 45(4):254. PubMed ID: 17668412 [No Abstract] [Full Text] [Related] [Next] [New Search]